Onvansertib in Combination With Nanoliposomal Irinotecan, Leucovorin, and Fluorouracil for Second-Line Treatment of Participants With Metastatic Pancreatic Ductal Adenocarcinoma
Clinical trial NCT04752696 · COMPLETED
Trial details
- NCT number
- NCT04752696
- Sponsor
- Cardiff Oncology
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-25
- Primary completion
- 2024-12-24
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.